Two vaccines (Gardasil & Cervarix) against cervical cancer are being widely used without sufficient evidence about whether they are worth their high cost or even whether they will effectively stop women from getting the disease, two articles in this week’s New England Journal of Medicine conclude.
read more | digg story
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment